Platelet glycoprotein IIb/IIIa receptor blockers: An appropriate-use model for expediting care in acute coronary syndromes

This publication has 37 references indexed in Scilit:

• Platelet activation in patients after an acute coronary syndrome: results from the TIMI-12 trial
  Journal of the American College of Cardiology, 1999
• Operator volume and outcome of patients undergoing coronary stent placement
  Journal of the American College of Cardiology, 1998
• Cost Advantages of an Ad Hoc Angioplasty Strategy
  Journal of the American College of Cardiology, 1998
• Ticlopidine-Aspirin as Antithrombotic Regimen for Intracoronary Stenting for Unstable Angina: Is there a Need for Further Antiplatelet Therapy?
  Journal of the American College of Cardiology, 1998
• Changes in platelet size and count in unstable angina compared to stable angina or non-cardiac chest pain
  European Heart Journal, 1998
• Long-term Protection From Myocardial Ischemic Events in a Randomized Trial of Brief Integrin β3 Blockade With Percutaneous Coronary Intervention
  JAMA, 1997
• Evidence for Prevention of Death and Myocardial Infarction With Platelet Membrane Glycoprotein IIb/IIIa Receptor Blockade by Abciximab (c7E3 Fab) Among Patients With Unstable Angina Undergoing Percutaneous Coronary Revascularization
  Journal of the American College of Cardiology, 1997
• Platelet Glycoprotein IIb/IIIa Receptor Blockade and Low-Dose Heparin during Percutaneous Coronary Revascularization
  New England Journal of Medicine, 1997
• Randomised placebo-controlled trial of effect of eptifibatide on complications of percutaneous coronary intervention: IMPACT-II
  The Lancet, 1997
• “High-risk” percutaneous transluminal coronary angioplasty
  The American Journal of Cardiology, 1988